• Aucun résultat trouvé

Abstracts, authors index

N/A
N/A
Protected

Academic year: 2022

Partager "Abstracts, authors index"

Copied!
54
0
0

Texte intégral

Références

Documents relatifs

When helping the minority of patients may hurt the majority: The case for DPD phenotyping and 5-fluorouracil therapeutic drug monitoring C Tron, F Lemaitre, Emeric Boisteau, S Le

Feasibility with a 55 nm Z-Ave loaded LNC gel with 10% drug concentration (Gem-C12/Labrafac w/w) was not performed due to the instantaneous gelation process directly aer the

Consumption may be expressed in terms of pharmaceutical firm turnover, therapeutic costs, weight (total weight or dose equivalent), treatment doses such as defined daily dose

Perrier A, Miron MJ, Desmarais S et al (2000) Using clinical evaluation and lung scan to rule out suspected pulmo- nary embolism: Is it a valid option in patients with normal results

[r]

For each medium, data are organised into three sections: (1) MICs for pWT isolates, including laboratory control strains (e.g. H37Rv), (2) MICs for isolates with mutations

– and EHSLC have established a general policy that distinguishes the control of any drug exposure for all illicit substances (doping control) and the control of a drug effect

This study uses individual- level green space exposure data linked to harmonised outcomes from four cohorts in ten cities across three European countries to examine the association